Risk of neural tube defects higher for babies of women on HIV therapy with dolutegravir
Children born to women on HIV therapy containing the drug dolutegravir since conception have a slightly higher risk of neural tube defects, compared to children born to women on regimens of other antiretroviral drugs.
Read Original Article: Risk of neural tube defects higher for babies of women on HIV therapy with dolutegravir »
